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Introduction
Pituitary hormone secretion regulates multiple functions in the body, including fertility, growth, fluid balance and the response to stress. This regulation displays annual oscillations in most mammalian species, and is overtly seasonal in animals that have a tightly controlled reproductive window. It is thought that both endogenous (circadian and circannual rhythm generators) and exogenous (photoperiod) cues can contribute to drive seasonal physiology [1] . The duration of nocturnal release of the pineal hormone melatonin underlies the photoperiodic control of seasonality in sheep [2] . As the synthesis and release of melatonin is inhibited by light, the longer nights of winter are associated with longer duration of melatonin production, whereas the opposite is true in the summer. Even though the reproductive cycle relies primarily on the secretion of gonadotropinreleasing hormone (GnRH) from the hypothalamus [3] , one of the major sites of melatonin action is the pars tuberalis (PT) of the pituitary gland [4, 5] . Indeed, melatonin is a regulator of endocrine function in the pituitary, and specifically inhibits prolactin-producing lactotrophs, known to be associated with repression of the reproductive cycle, directly within this tissue [6] . However, the mechanism through which melatonin exerts this influence remains unclear.
Three functionally distinct regions of the pituitary gland, the PT, pars distalis (PD) and infundibulum intercommunicate with one another via an elegant portal vascular arrangement. Although melatonin is known to act on its receptors in the PT, lactotrophs -the cells inhibited by melatonin, are exclusively found in the PD Angiogenesis dependent seasonal control of pituitary function 5 [7, 8] . The mechanisms through which melatonin, acting in the PT, can control pituitary function in the PD are unresolved. Here we describe how the vascular arrangement in the infundibulum of the pituitary was drastically altered between the breeding and non-breeding seasons (BS and NBS, respectively) in sheep.
We therefore tested the hypothesis that melatonin could act to regulate pituitary function through the control of blood vessel growth and communication between the PT and PD.
Blood vessel growth (angiogenesis) is regulated by vascular endothelial growth factors (VEGF), a family of peptides of which the most potently angiogenic and widely expressed is VEGF-A. Multiple VEGF-A products can be generated by alternative splicing of a single gene [9, 10] . Alternative use of exons 6 and 7 will result in proteins of different length (e.g. 120, 164 or 188 amino acids in sheep, and 121, 165 or 189 in human). Use of the proximal splice site in exon 8
generates the pro-angiogenic VEGF-Axxxa isoforms, and use of the distal splice site in exon 8 generates the VEGF-Axxxb isoforms, where xxx denotes the number of amino acids, and a or b denotes the carboxy-terminal amino acid sequence. The most extensively studied and highly expressed isoforms of each family (VEGF-A165b and VEGF-A165a, respectively) are able to counteract the effects of each other on blood vessel growth [11] . When VEGF-A165a binds VEGFR2 on endothelial cells it causes robust autophosphorylation and downstream signalling through phospholipase C, src, ras and other pathways to induce a raft of responses including angiogenesis, vasodilatation, increased vascular permeability and cytoprotection [12] .
Significance Statement
Adaptation to seasonal changes in the environment is critical for survival in all species. In vertebrates, annual oscillations in pituitary hormones underlie the regulation of seasonal physiology. We found that, in sheep, the duration of pineal melatonin output at night controls the production of different forms of the protein, vascular endothelial growth factor (VEGF) within a specific pituitary region, the pars tuberalis. Forms that block blood-vessel growth are made in winter, but those that stimulate it are made in summer. Further to the resulting remodelling of the vascular connection between the brain and pituitary, the temporally divergent VEGF-A variants operate as messenger signals on endocrine cells of a different part of the gland, the pars distalis, to regulate seasonal fertility.
In contrast, although the binding affinity for VEGFR2 is the same as that of VEGF-A165a, VEGF-A165b induces weak phosphorylation [13] , does not bind the co-receptor Neuropilin-1 [14 ] , which is responsible for intracellular trafficking and recycling to the membrane [15] , and does not activate the full signalling pathway.
This means it does not induce angiogenesis or vasodilatation [11] , or a sustained increase in vascular permeability [16] , and results in VEGFR2 degradation, not recycling [15] . It does, however, stimulate cytoprotection of endothelial and epithelial cells [17] and neurons [18] . These two isoform families, therefore, have very different physiological consequences [19] , but any differential role in seasonal pituitary angiogenesis is unknown. We found that while total VEGF-A was not altered between the BS and NBS, there was a dramatic switch in splicing in the BS from angiogenic VEGF-Axxxa isoforms to anti-angiogenic VEGF-Axxxb isoforms in both the PT and PD. This was mirrored by a reduction in the number of blood vessels in the infundibulum. Melatonin receptor expression in the PT and the infundibulum co-localized with cells expressing VEGF-A. Two potential mechanisms for VEGF-A-mediated regulation of pituitary seasonality are proposed here -a) VEGF-A acting to regulate blood vessel function, which subsequently controls delivery of other hormones to the PD, and b) VEGF-A acting directly on lactotrophs to control prolactin-associated down-regulation of the reproductive axis. We found that VEGFR2 co-localization with prolactin in the PD was increased outside the BS, consistent with a VEGF-Axxxa mediated repression of fertility. In vitro culture of PT cells from BS sheep showed that duration of melatonin exposure controlled VEGF-A isoform secretion -long exposure induced VEGF-Axxxb production, whereas short exposure induced VEGF-Axxxa production. Culture of PT cells from the NBS revealed that melatonin given at frequencies seen in the winter could switch the expression of VEGF-A isoforms to BS levels. We then showed that PT cells treated with NBS melatonin regimens release VEGF-Axxxa, which directly induced prolactin secretion from PD cells. Finally, the time-dependent, melatonin-induced differential expression of VEGF-A isoforms resulted in alterations of gonadotroph function opposite to those of lactotrophs in each season. Together, these results demonstrate that melatonin-mediated control of VEGF splicing could underlie intra-pituitary regulation of seasonal fertility. 
Results

Vascular growth in the pituitary gland is seasonally controlled
To investigate the vascular architecture of the pituitary in a seasonally breeding mammal, we screened pituitary glands of sheep with the endothelial marker CD31. Staining showed a significant (p<0.001) increase in the number of vascular loops extending from the PT into the infundibulum in the summer (nonbreeding season, NBS) compared with animals culled in the winter (breeding season, BS; Figure 1A ). To determine whether this was due to endothelial proliferation in the NBS, we co-stained for CD31 and proliferating cell nuclear antigen, PCNA. We detected proliferating endothelial cells in both seasons, but a two-fold increase in proliferating endothelial cells in the NBS ( Figure 1B ). As angiogenesis is driven by VEGF, we measured VEGF-A in the parstuberalis/stalk region of the pituitary. There was no difference in VEGF-A as measured by antibodies that detect all isoforms of VEGF-A (panVEGF; Figure 1C ). However, using antibodies that specifically detect the exon 8b splice variants (VEGF-Axxxb), the expression of which has been shown to be antiangiogenic in vivo, a reduction in VEGF-Axxxb was measured in the NBS ( Figure   1D ). This resulted in a change in the ratio of VEGF-A from 33% excess antiangiogenic isoforms in the BS, to 60% excess angiogenic isoforms in the NBS ( Figure 1E ). This indicates that the pituitary is in an anti-angiogenic state in the BS, and suggests a link between day length and VEGF-A splicing. To determine whether VEGF-A was expressed in the pituitary in cells that can respond to day length, we co-stained for melatonin receptor and VEGF. Figure 1F shows that MT1 and VEGF-A were co-localized in the PT and, interestingly, also in the vascular loops (arrows) that connect the PT with the infundibulum. In contrast, while VEGF-A was expressed in the PD, MT1 receptors were not. The antiangiogenic isoforms have not previously been cloned from sheep, so we examined RNA expression by RT-PCR. Both isoforms were detected in pituitaries from sheep in both seasons (PD and PT, supplementary Figure 1A ).
Cloning and sequencing of the PCR product confirmed that this was sheep VEGF-Axxxb (supplementary Figure 1B) . The sheep sequence has a single nucleotide substitution (a G in sheep, C in human) compared with human DNA.
This results in a single amino acid difference, with a sequence of SRTRKD instead of SLTRKD in human. Thus, the sheep VEGF-Axxxb isoforms are one amino acid shorter than the human ones. The cell type in which VEGF-Axxxb was expressed in the PT was identified by immunolocalization. Supplementary Figure   1C confirms that VEGF-Axxxb is expressed in the MT1 positive cells, which, in the PT, are not endothelial or glial-type folliculostellate (S100+) cells. These results suggested that melatonin could regulate expression of different VEGF-A isoforms in the PT, so regulating angiogenesis in the pituitary in a seasonally dependent manner.
VEGF-A splicing is regulated by duration of melatonin exposure in PT cells
We investigated VEGF-A isoform expression in cells isolated from the PT, which express both the melatonin receptor and VEGF-A (supplementary Figure 2A Figure   2B ). In contrast, when cells from pituitaries of NBS sheep were given the NBS melatonin regimen, VEGF-Axxxb was only increased 2-fold (significantly lower than BS, Figure 2A ), but panVEGF-A was increased 5-fold ( Figure 2B ), although this response took longer than in the BS cells. This suggests that the length of time that the cells are daily exposed to melatonin controls the expression of the different splice variants of VEGF-A. It also suggests that NBS cells are less prepared to respond to melatonin exposure, as they take longer to increase their VEGF-Axxxa output. To determine whether this was dependent on the stage of the annual reproductive cycle, we treated cells with a melatonin regimen that was reversed (i.e. opposite to that of the prevailing photoperiod) and found the same response for VEGF-Axxxb -BS regimen induced VEGF-Axxxb expression, whereas NBS regimen did not ( Figure 2C ). The same was true for panVEGF-A ( Figure   2D ) -expression was induced by both regimens, but NBS cells were slower to respond than BS cells. To confirm that this was due to a change in the RNA splice isoforms, we measured RNA levels of VEGF-A164b and VEGF-A1654a by quantitative RT-PCR using isoform specific primers. Figure 2E shows that VEGFA164a and VEGF-A164b were preferentially upregulated by the NBS and BS regimens, respectively, in BS cells. In NBS cells, the same effect was induced by switching the melatonin regimen, indicating that this effect is specific to the duration of melatonin exposure, rather than the stage of the annual reproductive cycle from which the cell was sourced. These results indicate that melatonin can control angiogenesis protein production in the PT.
VEGF-A splice isoforms and receptors are present in the PD
To determine whether VEGF-A could target endocrine and /or non-endocrine cells that are known to display seasonal plasticity, we screened the PD for the VEGF receptor, VEGFR2. Co-staining of VEGFR2 with folliculostellate cells (FSC, Figure 3A ) and lactotrophs (LT, Figure 3B ) showed that VEGFR2 was colocalized with a proportion of FSC and LT, and critically, that this co-localization increased (p<0.01 and p<0.001, respectively) during the non-breeding season (NBS), i.e. in the summer. There was also substantial VEGFR2 expression colocalized on endothelial cells in both seasons ( Figure 3C 
VEGF-A isoforms control seasonal endocrine function
These results lead to two hypotheses: a) that VEGF-A controls angiogenesis and this allows, by increased portal blood flow, an as yet unidentified compound to repress the reproductive axis (presumably, at least in part, by stimulating prolactin); and/or b) that VEGF-A itself is a signalling molecule from the PT to the PD, which directly contributes to the inhibitory regulation of the reproductive cycle by releasing prolactin. To test this latter hypothesis, we cultured PD cells from sheep in the NBS or BS and treated them with recombinant human VEGF-A165a (rhVEGF-A165a) or conditioned media from the PT cells taken at the same time of year, and measured prolactin production by radioimmunoassay. Figure 4A shows that VEGFR2 and prolactin were both expressed by PD cells in culture. Figure 4B shows that the cells from both NBS and BS animals could be induced to release 13 prolactin by thyrotropin-releasing hormone (TRH), but not by melatonin. Figure   4C shows that rhVEGF-A165a, given for the duration that matches NBS melatonin exposure (i.e. 8 hrs in the summer), resulted in significant prolactin release from PD cells from NBS animals (p<0.001), and from cells from the BS (supplementary Figure 3A) . It also showed that rhVEGF-A165a, given at BS duration (16 hours) did not cause prolactin release from BS ( Figure 4C ) or NBS cells (supplementary Figure 3A) . We confirmed this at the RNA level ( Figure 4D Figure 3B) . Critically, this effect was completely blocked by an antibody to VEGF-Axxxa ( Figure 4F , G). Conditioned media from PT cells treated with BS melatonin regimen had no effect on prolactin production from breeding season PD cells ( Figure 4F ), but did stimulate FSH mRNA production from these cells (supplementary Figure 3C) , and from cells from non breeding season ewes (supplementary Figure 3D ), an effect which was inhibited by pre-treatment with a VEGF-Axxxb specific antibody (supplementary Figure 3D ). This indicates that melatonin duration-induced differential VEGF-A isoform production by the PT has the potential to regulate the seasonal production of prolactin and FSH by the PD through an intra-pituitary paracrine mechanism mediated by VEGF. The microvasculature of the pituitary gland is key to the regulation of multiple body functions because it controls the blood flow from the hypothalamus, altering the delivery of stimulatory and inhibitory signals to endocrine target cells [20] .
Here we show that this vascular connection undergoes a remarkable seasonal adaptation throughout the annual reproductive cycle in response to an external cue, namely the changing photoperiod. Such vascular plasticity is manifested in alterations of endothelial cell proliferation that result in timely changes in the vascular loops that connect the PT with the infundibulum before giving rise to the long portal vessels which terminate in the PD. Even though these loops were first described over six decades ago [21] , the possibility that they could alter the connectivity between the brain and the pituitary at certain times of the year was not known. Although no apparent alterations in the ovine pituitary vasculature of male castrates exposed to different photoperiods was recently reported, detailed measurements were not undertaken and the vascular loops were not specifically examined [22] . The increased number and surface area of these vascular loops during the long days of the NBS, concomitant with an increase in endothelial cell proliferation, is in agreement with the increased number of cells proliferating in the PT shown in this study and by another group [23] at this time of year. [24] . This remodelling could substantially increase or decrease the transport of hormones from the PT to the infundibulum and from the infundibulum to the PD, thus being able to accentuate or reduce the effect of hypothalamic derived neuroendocrine signals, such as GnRH, to the hormone producing cells of the pituitary. It is possible that this regulatory mechanism for the delivery of hypothalamic factors could operate in conjunction with the dynamic retraction / protraction of 'endfeet' processes of tanycytes [25] , the specialized ependymal cells of the glia, which have been shown to interact with the hypothalamic neuronal terminals and fenestrated capillaries of the median eminence and to play a role in the control of the seasonal reproductive cycle in birds [26] . The VEGF isoforms have been shown to differentially regulate fenestrations of endothelial cells [16] , so it is possible that the two mechansims could work together, although we are unable to use the evidence presented here to differntiate between dependnet and independent mechanisms.
In other tissues, vascular remodelling and permeability is controlled by VEGF-A show that in addition to the PT-specific cells, melatonin could also act directly on the vascular loops, revealing a previously unknown target for melatonin action to translate photoperiodic effects on seasonal physiology. As the blood flows from the brain to the pituitary [11] , alterations in the vascular loops of the infundibulum that will give rise to the long portal vessels [12] could contribute not only to regulate the transfer of PT products to the PD, but also to alter the delivery of hypothalamic factors; thus, the increased vascular connections during the long days of summer would be expected to favor increased supply of stimulatory and inhibitory hypothalamic signals to the PD at this time of year. Notwithstanding, the reduction in vascularity during the short days of winter is likely to play a role Notably, we show that, in addition to its actions on the pituitary vasculature and FS cell population, VEGF-A has a potent prolactin releasing effect, and that this stimulation depends on time of exposure of the ligand and density of VEGF receptors in lactotrophs, which is increased during the long days of the NBS.
Moreover, these stimulatory effects of VEGF-A on prolactin synthesis and release were accompanied by suppression of the gonadotrophic axis, as revealed by inhibition of FSH gene expression. Melatonin was shown to mediate the photoperiodic regulation of prolactin secretion through a direct action within the pituitary gland [6] . Because MT1 melatonin receptors are selectively expressed in the PT, and this region is deprived of lactotroph cells [7, 8] A on prolactin were mimicked by conditioned media from PT cultures exposed to a NBS regimen of melatonin, and that these actions of PT media were blocked by a specific VEGF-Axxxa antibody, demonstrating that VEGF-A is a potential paracrine signal, and that melatonin-induced differential VEGF-A isoform production by the PT can regulate the seasonal production of both prolactin and FSH. Because these effects were also recorded in PD cells obtained in the opposite season (i.e. BS), albeit with a three-day lag required for adaptation, our results show that the photoperiodically-induced paracrine mechanism mediated by VEGF-A can ultimately override the circannual phase of the PD target cells, and entrain it to the new photoperiod. The increased VEGF receptor content in the PD during the NBS plays a major role in mediating this process, and thus in the biological adaptation to a summer physiology, because VEGF-A treatments mimicking a NBS melatonin regimen showed a delayed response in BS cultures where the VEGF receptor content was reduced. with the presence of a large follicle (> 2 cm). By contrast, in the NBS, ewes were considered to be anestrus when no CL but a corpus albicans was observed in the gonad, and follicles present were < 2 mm diameter.
Materials and Methods
Details
Expression studies
Pituitaries were stained and RNA was extracted 
Statistical analysis
In both the BS and NBS cultures, a total of five separate experimental treatments were applied to PT cells, and nine experimental treatments applied to the PD cells. For each treatment, six wells were assigned, and the experiments were repeated independently three times in both seasons with reproducible results.
The reported values represent the mean +/-SEM. The effects of season, experimental treatment and their interaction on the secretion VEGF-A and prolactin from ovine primary pituitary cell cultures were examined using ANOVA followed by Fisher's post-hoc test. Because a season by treatment interaction was observed for each compound, separate ANOVAS were then used to examine the effects of experimental treatment within season. For all other variables one-way ANOVA was applied. All data were confirmed to be normally distributed by D'Agostino and Pearson omnibus normality test. Data were considered to be statistically significant when p<0.05; however, wherever detected, smaller log value (p<0.01, p<0.001) probabilities are reported.
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EXPERIMENTAL PROCEDURES
Ovine pituitary glands were obtained from ovary-intact females during the breeding season (BS -December ⁄January) and the non-breeding season (NBSJune ⁄July). Animals were killed for commercial reasons at an abattoir (University of Bristol Abattoir, Langford, UK) and pituitaries removed immediately after death. During the BS, ewes were confirmed to be sexually active on the basis of a recently formed corpus luteum (CL) together with the presence of a large follicle (> 2 cm). By contrast, in the NBS, ewes were considered to be anestrus when no CL but a corpus albicans was observed in the gonad, and follicles present were < 2 mm diameter.
Immuno-fluorescent staining
Pituitaries assigned for immunofluorescent staining (BS n = 6; NBS n =6) were fixed in Bouin's solution for 24 hrs and then moved to 70% ethanol, and sectioned at 5m. Following sequential dehydration, sections were submerged in PBS-T (0.1% Triton-X) and then 0.01M sodium citrate buffer (pH6; Sigma) and heated for 3 min at full power, and 12 min at sub-boiling temperature. Sections were then washed in PBS-T (3 x 5 min), and blocked in 5% goat serum diluted in 1% BSA PBS-T (0.01%) for 2 hrs at RT. A range of primary antibodies were used for double florescent immunohistochemistry (IMF), each diluted to a concentration determined during preliminary investigations (Table 1) . Secondary antibodies were diluted as outlined in Table 2 and left to incubate on the section for 2 hrs at RT.
cDNA synthesis and RT-PCR and RT-qPCR
Pituitaries assigned for DNA analysis of VEGF-A expression were flash-frozen in liquid nitrogen following dissection. RNA Extraction was carried out by TRI reagent method, itself a modification from the original phenol/chloroform extraction developed by Chomczynski et al. [60] . Multiple pairs of primers were used to amplify the various VEGF-A isoforms (Table 3) . To generate cDNA, 2μg of RNA and 2 units of RNase-Free DNase (RQ1, M6101, Promega) were incubated in a 1x reaction buffer solution for 1 hour at 37°C, before 1μl of DNase stop solution was added to terminate the reaction, and the sample was heat inactivated for 10 minutes at 65°C. The DNase-treated RNA sample was requantified by using a Nanodrop ND-1000 spectrophotometer and 1μg of RNA was re-suspended to a total volume of 10μl. To this, 2μl of Oligo (dT) 15 primers (C1101, Promega) and 1μl of hexamers (Random Primers, C1181, Promega) were added. The reaction mix was then incubated at 70°C for 10 minutes before immediately being quenched on ice for 5 minutes. With a final reverse transcription reaction volume of 50μl, 400 units of MMLV reverse transcriptase (M5301, Promega), 40 units of RNasin ribonuclease inhibitor (N2611, Promega) and 0.5mM dNTPs (BIO-39049, Bioline) were added to the RNA/primer mix. The reaction was incubated for 1.5 hours at 37°C with a final 70°C inactivation step. Final concentration of fresh cDNA was determined by spectrophotometry.
For RT-PCR, forward and reverse primer (1μM, see Table 3 ) were added each with 1.2mM MgCl2, 200μM deoxynucletide triphosphates, and 1 unit of Taq polymerase (Abgene, Thermo-Fischer, Epsom, UK). PCR was undertaken for 35 cycles, at 95°C for 1 min, 60°C for 5 mins and 72°C for 5 mins with a 2 minute 95°C denaturing step at the beginning and a 72°C extension step at the end. PCR products were run on 3% agarose gels containing 0.5 μg/ml Ethidium Bromide and visualized under a UV transilluminator. For RT-qPCR, cDNA was added to 5.5μl of SYBRG fast track with Rox (Kappa Biosystems, Wilmington, Massachusetts, USA), 1µM of each primer in a total of 18µl. Samples were loaded in triplicate and a negative control of water was added. GAPDH was used as a reference gene.
Primary cell cultures
Ovine primary pituitary cultures were produced using a method previously described [61] . Briefly, the pars distalis (PD) and pars tuberalis (PT) of 3-4 pituitaries were carefully dissected and incubated in a 0.1% collagenase D (Boehringer Mannheim, Mannheim, Germany) and hyaluronidase (Sigma-Aldrich, Poole, UK) solution in a shaking water bath at 37 °C for 75 min. The tissue was then manually dispersed in phosphate-buffered saline (Sigma-Aldrich) and the mixed pituitary cells re-suspended in M199 medium (Invitrogen, Paisley, UK) containing 10 mg ⁄ ml of insulin, 50 mg ⁄ ml of gentamicin, 100 IU ⁄ ml of penicillinstreptomycin (Sigma-Aldrich) and 10% steroid-free lamb serum (Invitrogen), before being plated at a density of 200 000 cells ⁄ well in 24-well plates. The experiment was repeated three times each in the BS and NBS, totalling 9-12 animals per season. During both the BS and the NBS, cells were maintained in culture for 6 days. M199 media was changed at each time point outlined below. Previous studies have demonstrated the validity of this method for producing a reliable hormone output in response to exogenous hormone releasing secretagogues in vitro [61, 62] .
PT cells were assigned one of the following treatments; i) Control -M199 media alone, changed daily at 5pm and 9am; ii) BS regimen -melatonin (1µM), administered at 5pm, removed at 9am, media alone administered from 9am until 5pm; iii) NBS regimen -melatonin administered at 9pm, removed at 5am, media from 5am until 9pm. Three experimental groups of PT cells per season were used. Six wells were assigned per treatment, 3 wells used for RNA based assays, and 3 wells for protein based assays. In one repeat of each experiment per season, 1 well per treatment was used for IMF. PD cells were treated with the following treatments: i) Control (C) -M199 media alone, changed every day at 5pm and 9am; ii) BS regimen -recombinant human VEGF-A165a (1nM rh.VEGF-A165a ), or 1µM melatonin, or 0.1µM thyrotropin releasing hormone (TRH), or conditioned media from PT cells treated as above administered at 5pm, removed at 9am, and media alone administered from 9am until 5pm; iii) NBS regimen rh.VEGF-A165a melatonin, or TRH, or conditioned media from PT cells treated as above, administered at 9pm, removed at 5am, media alone administered from 5am until 9pm. Rh.VEGF-A165a was administered at 1nM based on preliminary investigations that produced a VEGF-A dose response to melatonin from PT primary cells in culture.
Total protein quantification
Measurement of total protein was determined using the BioRad Protein Assay. 
